AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site K126A
Virus MERS-CoV
Mutation level Amino acid level
Gene/protein/region type ORF1ab(nsp1)
Gene ID 14254602
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence JX869059.2
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity decrease
Pathogenicity mechanism To investigate the biological functions of MERS-CoV nsp1-mt, we independently transfected 293 cells with capped and polyadenylated RNA transcripts encoding chloramphenicol acetyltransferase (CAT), SARS-CoV nsp1, wild-type MERS-CoV nsp1 (MERS-CoV nsp1-WT),
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name 1AB polyprotein
Uniprot protein ID K9N7C7
Protein length 7078 amino acids
Protein description ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins.MERS-CoV nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies.

Literature information:


Pubmed ID 30111568
Clinical information No
Disease -
Published year 2018
Journal Journal Of Virology
Title The Endonucleolytic RNA Cleavage Function of nsp2 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines
Author Keisuke Nakagawa,Krishna Narayanan,Masami Wada,vsevolod L Popov,Maria Cajimat
Evidence MERS-CoV nsp1-mt, and MERS-CoV nsp1 mutant carrying R125A and K126A mutation (MERS-CoV nsp1-CD), the latter of which lacks the endonucleolytic RNA cleavage activity but retains the translation suppression function (43).